Clinical Trials
57 trialsA Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
ESTIMATE
Yunnan Cancer Hospital
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial
Sichuan Cancer Hospital and Research Institute
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Sun Yat-sen University
Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
RACE-GB
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Zhejiang Cancer Hospital
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
Sixth Affiliated Hospital, Sun Yat-sen University
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Peking Union Medical College Hospital
Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
Hellenic GenitoUrinary Cancer Group
Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer
Wuhan University
Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor
Sun Yat-sen University
Study to Nivolumab Following Preoperative Chemoradiotherapy
National Cancer Center Hospital East
Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC
First Affiliated Hospital of Zhejiang University
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients
Second Affiliated Hospital, School of Medicine, Zhejiang University
OITROLC
Sichuan Cancer Hospital and Research Institute
Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer
Peking Union Medical College Hospital
Study of Endostar Combined With TP Regimen for Esophageal Cancer
Second Affiliated Hospital of Xi'an Jiaotong University
INDUCTION
Barretos Cancer Hospital
NAC Followed by RH for the Treatment of LACC
Peking Union Medical College Hospital
Organ Preservation in Elderly Patients With Rectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology
CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC
Fudan University
Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy
Shanghai Zhongshan Hospital
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients
Shandong Cancer Hospital and Institute
Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer
Affiliated Hospital of North Sichuan Medical College
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
Russian Academy of Medical Sciences
TNTCRT
West China Hospital
A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)
Sun Yat-sen University
A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Henan Cancer Hospital
Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC
Tianjin Medical University Cancer Institute and Hospital
Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy
Sun Yat-sen University
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer
Assiut University
HEATPAC
Kantonsspital Aarau
IFCSLAPC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma
Fudan University
Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer
Changzhou No.2 People's Hospital
Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
Biotech Pharmaceutical Co., Ltd.
Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck Cancer
University Hospital Tuebingen
Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.
A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University